Latest News and Press Releases

- Pam Stetkiewicz, Ph.D., Appointed Chief Operating Officer - Kathryn McCabe, Ph.D., Named SVP, Head of Business Development CAMBRIDGE, Mass., July 20, 2021 (GLOBE NEWSWIRE) -- Arbor...

CAMBRIDGE, Mass., June 21, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early-stage life sciences company discovering and developing the next generation of genetic medicines, announced today...

CAMBRIDGE, Mass., June 02, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early-stage life sciences company discovering and developing the next generation of genetic medicines, announced today...

CAMBRIDGE, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early-stage life sciences company discovering and developing the next generation of genetic medicines, announced today...

CAMBRIDGE, Mass., April 01, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early-stage life sciences company unlocking nature’s genetic diversity to enable revolutionary gene editing...

CAMBRIDGE, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies announced today the appointment of Mark D. Angelino, co-founder and former Chief Operating Officer of Generation Bio, to...

The new agreement will provide Lonza with access to Arbor’s gene editing technology Quote from David Cheng, CEO of Arbor: “Arbor's differentiated gene editing technologies allow Lonza to manufacture...

CAMBRIDGE, Mass., Sept. 25, 2019 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early-stage life sciences company, today announced that the United States Patent and Trademark Office (USPTO) has...

CAMBRIDGE, Mass., July 09, 2019 (GLOBE NEWSWIRE) -- Arbor Biotechnologies (Arbor), an early-stage biodiscovery company, announced today that it has been selected for STEX25, an MIT Startup Exchange...

Discovers three new CRISPR-Cas systems, findings published in the journal ScienceAppoints Paul Meister to its Board of Directors CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Arbor...